or
forgot password
  • cancer clinical trials in los angeles, CA

  • Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
    Cedars-Sinai Medical Center
    Los Angeles, California 90048
    Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Breast Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    University of Southern California
    Los Angeles, California 90033
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Pancreatic Cancer
    S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Bladder Cancer
    Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer
    University of Southern California
    Los Angeles, California 90033
    Recurrent Uterine Sarcoma, Stage III Uterine Sarcoma, Stage IV Uterine Sarcoma, Uterine Carcinosarcoma
    Radiation Therapy in Treating Young Patients With Gliomas
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

    Trial Locations
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Jonsson Comprehensive Cancer Center at UCLA
    Childrens Hospital Los Angeles
    Brain Tumor, Central Nervous System Tumor
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Fallopian Tube Cancer, Ovarian Cancer
    Cysteine Supplementation in Critically Ill Neonates
    UCLA Medical Center, Mattel Childrens Hospital
    Los Angeles, California 90095
    Sepsis, Bronchopulmonary Dysplasia, Necrotizing Enterocolitis, Retinopathy of Prematurity, Systemic Inflammatory Response Syndrome
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Kenmar Research Institute LLC

    Trial Locations
    Kenmar Research Institute LLC
    UCLA Medical Ctr
    Non-Small Cell Lung Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of California at Los Angeles (UCLA )

    Trial Locations
    University of California at Los Angeles (UCLA )
    Kaiser Permanente Medical Care Program - Los Angeles Medical Center & Sunset Hospital
    Kaiser Permanente Los Angeles Medical Center
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Head and Neck Cancer
    Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas
    University of California at Los Angeles (UCLA )
    Los Angeles, California 90095
    Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Adult Mixed Glioma, Recurrent Adult Brain Tumor
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Jonsson Comprehensive Cancer Center at UCLA

    Trial Locations
    Jonsson Comprehensive Cancer Center at UCLA
    Childrens Hospital Los Angeles
    Leukemia
    FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer
    USC/Norris Comprehensive Cancer Center
    Los Angeles, California 90033-0800
    Prostate Cancer
    Fenretinide LXS in Treating Patients With Recurrent, Refractory, or Persistent Neuroblastoma
    Childrens Hospital Los Angeles
    Los Angeles, California 90027
    Neuroblastoma
    Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Kidney Cancer
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Children's Hospital Los Angeles
    Los Angeles, California 90027-0700
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center
    Los Angeles, California 90048-1865
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Vaccine Therapy in Treating Patients With Newly Diagnosed Stage IV Kidney Cancer
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Kidney Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    University of Southern California

    Trial Locations
    University of Southern California
    Jonsson Comprehensive Cancer Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Breast Cancer
    Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
    UCLA Center for Health Sciences
    Los Angeles, California 90095
    Anemia, Aplastic
    Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    Kenmar Research Institute

    Trial Locations
    Kenmar Research Institute
    University of California at Los Angeles
    Breast Cancer
    Cisplatin, Fluorouracil, Cetuximab, and Radiation Therapy in Treating Patients With HIV and Stage I, Stage II, or Stage III Anal Cancer
    UCLA Clinical AIDS Research and Education (CARE) Center
    Los Angeles, California 90024
    Anal Cancer
    AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Lung Cancer, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Imatinib Mesylate in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    University of Southern California

    Trial Locations
    University of Southern California
    Kaiser Permanente Los Angeles Medical Center
    Kaiser Permanente-West Los Angeles
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Fludarabine-based Conditioning for Severe Aplastic Anemia
    City of Hope National Medical Center

    Trial Locations
    City of Hope National Medical Center
    Mattel Children's Hospital at UCLA
    Anemia, Aplastic
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Kaiser Permanente Medical Center - Los Angeles
    Los Angeles, California 90027
    Prostate Cancer
    Belinostat and Isotretinoin in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by Surgery
    University of Southern California
    Los Angeles, California 90033
    Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Childrens Hospital Los Angeles
    Los Angeles, California 90027
    Kidney Cancer
    PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
    Jonsson Comprehensive Cancer Center at UCLA
    Los Angeles, California 90095-1781
    Leukemia
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    Children's Hospital Los Angeles
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    Children's Hospital Los Angeles

    Trial Locations
    Children's Hospital Los Angeles
    David Geffen School of Medicine at UCLA
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
    USC/Norris Comprehensive Cancer Center and Hospital
    Los Angeles, California 90033-0804
    Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
    Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor
    Cedars-Sinai Medical Center

    Trial Locations
    Cedars-Sinai Medical Center
    Children's Hospital Los Angeles
    Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor